Ischemia-reperfusion: From cell biology to acute kidney injury

Progres en Urologie

Volumn 24, Issue SUPPL.1, 2014, Pages

  Chatauret, N ^a,b   Badet, L ^a   Barrou, B ^a   Hauet, T ^a,b,c  

^a INSERM   (France)

^b POITIERS UNIVERSITY HOSPITAL   (France)

^c IBISA Domaine expérimental du Magneraud   (France)

Author keywords

Acute Kidney Injury; Chronic allograft nephropathy; Innate Immune Response; Ischemia reperfusion injury; Reactive oxygen species

Indexed keywords

ACUTE KIDNEY INJURY; COMPLICATION; CYTOLOGY; HUMAN; KIDNEY; KIDNEY TRANSPLANTATION; REPERFUSION INJURY; VASCULARIZATION;

ACUTE KIDNEY INJURY; HUMANS; KIDNEY; KIDNEY TRANSPLANTATION; REPERFUSION INJURY;

EID: 84902529003     PISSN: 11667087     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1166-7087(14)70057-0     Document Type: Article

References (73)

1. Bonventre J.V., Yang L. Cellular pathophysiology of ischemic acute kidney injury. J. Clin. Invest 2011, 121(11):4210-4221. nov.
2. Munshi R., Hsu C., Himmelfarb J. Advances in understanding ischemic acute kidney injury. BMC Med 2011, 9:11.
3. Coca S.G., Yusuf B., Shlipak M.G., Garg A.X., Parikh C.R. Long-term risk of mortality and other adverse outcomes after acute kidney injury: a systematic review and meta-analysis. Am. J. Kidney Dis 2009, 53(6):961-973. juin.
4. Yarlagadda S.G., Coca S.G., Garg A.X., Doshi M., Poggio E., Marcus R.J., et al. Marked variation in the definition and diagnosis of delayed graft function: a systematic review. Nephrol. Dial. Transplant 2008, 23(9):2995-3003. sept.
5. Hall I.E., Doshi M.D., Poggio E.D., Parikh C.R. A comparison of alternative serum biomarkers with creatinine for predicting allograft function after kidney transplantation. Transplantation 2011, 91(1):48-56. janv 15.
6. Perico N., Cattaneo D., Sayegh M.H., Remuzzi G. Delayed graft function in kidney transplantation. Lancet 2004, 364(9447):1814-1827.
7. Kalogeris T., Baines C.P., Krenz M., Korthuis R.J. Cell biology of ischemia/reperfusion injury. Int Rev Cell Mol Biol 2012, 298:229-317.
8. Kosieradzki M., Rowinski W. Ischemia/reperfusion injury in kidney transplantation: mechanisms and prevention. Transplantation proceedings 2008, 40(10):3279-3288.
9. Di Lisa F., Canton M., Menabò R., Kaludercic N., Bernardi P. Mitochondria and cardioprotection. Heart Fail Rev 2007, 12(3-4):249-260. déc.
10. Sugiyama S., Hanaki Y., Ogawa T., Hieda N., Taki K., Ozawa T. The effects of SUN 1165, a novel sodium channel blocker, on ischemia-induced mitochondrial dysfunction and leakage of lysosomal enzymes in canine hearts. Biochem. Biophys. Res. Commun 1988, 157(2):433-439. déc 15.
11. Kako K., Kato M., Matsuoka T., Mustapha A. Depression of membrane- bound Na+ -K+ -ATPase activity induced by free radicals and by ischemia of kidney. Am. J. Physiol 1988, 254(2 Pt 1):C330-C337. févr.
12. Kato M., Kako K.J. Effects of N-(2-mercaptopropionyl)glycine on ischemic-reperfused dog kidney in vivo and membrane preparation in vitro. Mol. Cell. Biochem 1987, 78(2):151-159. déc.
13. Roberts B.N., Christini D.J. NHE inhibition does not improve Na(+) or Ca(2+) overload during reperfusion: using modeling to illuminate the mechanisms underlying a therapeutic failure. PLoS Comput Biol 2011, 7(10):e1002241. oct.
14. Inserte J, Hernando V, Garcia-Dorado D. Contribution of calpains to myocardial ischemia/reperfusion injury. Cardiovascular research [Internet] 2012 juill 10 [cité 2012 aoÛt 22]; Available de: http://www.ncbi.nlm.nih.gov/pubmed/22787134.
15. Sanada S, Komuro I, Kitakaze M. Pathophysiology of Myocardial Reperfusion Injury: Preconditioning, Postconditioning and Translational Aspects of Protective Measures. American Journal of Physiology. Heart and Circulatory Physiology [Internet] 2011 aoÛt 19 [cité 2011 oct 13]; Available de: http://www.ncbi.nlm.nih.gov/pubmed/21856909.
16. Miyata H., Lakatta E.G., Stern M.D., Silverman H.S. Relation of mitochondrial and cytosolic free calcium to cardiac myocyte recovery after exposure to anoxia. Circ. Res 1992, 71(3):605-613. sept.
17. Peng T.-I., Jou M.-J. Oxidative stress caused by mitochondrial calcium overload. Ann. N. Y. Acad. Sci 2010, 1201:183-188. juill.
18. Javadov S., Hunter J.C., Barreto-Torres G., Parodi-Rullan R. Targeting the mitochondrial permeability transition: cardiac ischemia-reperfusion versus carcinogenesis. Cell. Physiol. Biochem 2011, 27(3-4):179-190.
19. Gustafsson A.B., Gottlieb R.A. Heart mitochondria: gates of life and death. Cardiovasc. Res 2008, 77(2):334-343. janv 15.
20. Becker L.B. New concepts in reactive oxygen species and cardiovascular reperfusion physiology. Cardiovasc. Res 2004, 61(3):461-470. févr 15.
21. Alkaitis M.S., Crabtree M.J. Recoupling the cardiac nitric oxide synthases: tetrahydrobiopterin synthesis and recycling. Curr Heart Fail Rep 2012, 9(3):200-210. sept.
22. Li C., Jackson R.M. Reactive species mechanisms of cellular hypoxia-reoxygenation injury. Am. J. Physiol., Cell Physiol 2002, 282(2):C227-C241. févr.
23. Bayrak O., Bavbek N., Karatas O.F., Bayrak R., Catal F., Cimentepe E., et al. Nigella sativa protects against ischaemia/reperfusion injury in rat kidneys. Nephrol. Dial. Transplant 2008, 23(7):2206-2212. juill.
24. Vanden Hoek T.L., Shao Z., Li C., Zak R., Schumacker P.T., Becker L.B. Reperfusion injury on cardiac myocytes after simulated ischemia. Am. J. Physiol 1996, 270(4 Pt 2):H1334-H1341. avr.
25. Kadenbach B., Ramzan R., Moosdorf R., Vogt S. The role of mitochondrial membrane potential in ischemic heart failure. Mitochondrion 2011, 11(5):700-706. sept.
26. Kanduc D., Mittelman A., Serpico R., Sinigaglia E., Sinha A.A., Natale C., et al. Cell death: apoptosis versus necrosis (review). Int. J. Oncol 2002, 21(1):165-170. juill.
27. Gottlieb R.A. Cell death pathways in acute ischemia/reperfusion injury. J. Cardiovasc Pharmacol Ther 2011, 16(3-4):233-238. déc.
28. Baines C.P. How and when do myocytes die during ischemia and reperfusion: the late phase. J. Cardiovasc Pharmacol Ther 2011, 16(3-4):239-243. déc.
29. Saikumar P., Dong Z., Weinberg J.M., Venkatachalam M.A. Mechanisms of cell death in hypoxia/reoxygenation injury. Oncogene 1998, 17(25):3341-3349. déc 24.
30. Belzer F.O., Southard J.H. Principles of solid-organ preservation by cold storage. Transplantation 1988, 45(4):673-676. avr.
31. Tveita T., Johansen K., Lien A.H., Myklebust R., Lindal S. Morphologic changes in tubular cells from in situ kidneys following experimental hypothermia and rewarming. APMIS 2005, 113(1):13-20. janv.
32. Hochachka P.W. Defense strategies against hypoxia and hypothermia. Science 1986, 231(4735):234-241. janv 17.
33. Rauen U., Polzar B., Stephan H., Mannherz H.G., de Groot H. Coldinduced apoptosis in cultured hepatocytes and liver endothelial cells: mediation by reactive oxygen species. FASEB J 1999, 13(1):155-168. janv.
34. Al-Awqati Q., Oliver J.A. Stem cells in the kidney. Kidney international 2002, 61(2):387-395.
35. Koo D.D., Welsh K.I., West N.E., Channon K.M., Penington A.J., Roake J.A., et al. Endothelial cell protection against ischemia/reperfusion injury by lecithinized superoxide dismutase. Kidney Int 2001, 60(2):786-796. aoÛt.
36. Stolz D.B., Ross M.A., Ikeda A., Tomiyama K., Kaizu T., Geller D.A., et al. Sinusoidal endothelial cell repopulation following ischemia/reperfusion injury in rat liver transplantation. Hepatology 2007, 46(5):1464-1475. nov.
37. White L.E., Cui Y., Shelak C.M.F., Lie M.L., Hassoun H.T. Lung endothelial cell apoptosis during ischemic acute kidney injury. Shock 2012, 38(3):320-327. aoÛt.
38. Faller D.V. Endothelial cell responses to hypoxic stress. Clin Exp Pharmacol. Physiol 1999, 26(1):74-84. janv.
39. Brezis M., Rosen S. Hypoxia of the renal medulla--its implications for disease. N. Engl. J. Med. 1995, 332(10):647-655. mars 9.
40. Silva P. Energy and fuel substrate metabolism in the kidney. Semin Nephrol 1990, 10(5):432-444. sept.
41. Bagnasco S., Good D., Balaban R., Burg M. Lactate production in isolated segments of the rat nephron. Am J Physiol 1985, 248(4 Pt 2):F522-F526. avr.
42. Brezis M., Rosen S., Silva P., Epstein F.H. Renal ischemia: a new perspective. Kidney Int 1984, 26(4):375-383. oct.
43. Lameire N., Van Biesen W., Vanholder R. Acute kidney injury. Lancet 2008, 372(9653):1863-1865. nov 29.
44. Kwon O., Hong S.-M., Ramesh G., Diminished N.O. generation by injured endothelium and loss of macula densa nNOS may contribute to sustained acute kidney injury after ischemia-reperfusion. Am J Physiol Renal Physiol 2009, 296(1):F25-F33. janv.
45. Molitoris B.A., Sandoval R., Sutton T.A. Endothelial injury and dysfunction in ischemic acute renal failure. Critical care medicine 2002, 30(5 Suppl):S235-S240.
46. Basile DP, Friedrich JL, Spahic J, Knipe NL, Mang HE, Leonard EC, et al. Impaired endothelial proliferation and mesenchymal transition contribute to vascular rarefaction following acute kidney injury. American journal of physiology [Internet]. Available de: file: //C: \article\21123492.pdf.
47. Legrand M., Mik E.G., Johannes T., Payen D., Ince C. Renal hypoxia and dysoxia after reperfusion of the ischemic kidney. Molecular medicine (Cambridge Mass.) 2008, 14(7-8):502-516.
48. Molitoris B.A., Sutton T.A. Endothelial injury and dysfunction: role in the extension phase of acute renal failure. Kidney international 2004, 66(2):496-499.
49. Lameire N., Van Biesen W., Vanholder R. Acute renal failure. Lancet 2005, 365(9457):417-430. févr 29.
50. Blantz R.C., Deng A., Miracle C.M., Thomson S.C. Regulation of kidney function and metabolism: a question of supply and demand. Trans Am Clin Climatol Assoc 2007, 118:23-43.
51. Eltzschig H.K., Eckle T. Ischemia and reperfusion--from mechanism to translation. Nat Med 2011, 17(11):1391-1401.
52. Thurman J.M. Triggers of inflammation after renal ischemia/reperfusion. Clin Immunol 2007, 123(1):7-13. avr.
53. Jang HR, Ko GJ, Wasowska BA, Rabb H. The interaction between ischemia-reperfusion and immune responses in the kidney. Journal of molecular medicine (Berlin, Germany) [Internet]. 2009; Available de: file: //C: \article\19562316.pdf.
54. He C.J., Peraldi M.N., Adida C., Rebibou J.M., Meulders Q., Sraer J.D., et al. Thrombin signal transduction mechanisms in human glomerular epithelial cells. J Cell Physiol 1992, 150(3):475-483. mars.
55. Chambers R.C., Laurent G.J. Coagulation cascade proteases and tissue fibrosis. Biochem Soc Trans 2002, 30(2):194-200. avr.
56. Grandaliano G., Monno R., Ranieri E., Gesualdo L., Schena F.P., Martino C., et al. Regenerative and proinflammatory effects of thrombin on human proximal tubular cells. J Am Soc Nephrol 2000, 11(6):1016-1025. juin.
57. Gui Y., Loutzenhiser R., Hollenberg M.D. Bidirectional regulation of renal hemodynamics by activation of PAR1 and PAR2 in isolated perfused rat kidney. Am J Physiol Renal Physiol 2003, 285(1):F95-F104. juill.
58. Erlich J.H., Boyle E.M., Labriola J., Kovacich J.C., Santucci R.A., Fearns C., et al. Inhibition of the tissue factor-thrombin pathway limits infarct size after myocardial ischemia-reperfusion injury by reducing inflammation. Am J Pathol 2000, 157(6):1849-1862. déc.
59. Hölschermann H., Bohle R.M., Schmidt H., Zeller H., Fink L., Stahl U., et al. Hirudin reduces tissue factor expression and attenuates graft arteriosclerosis in rat cardiac allografts. Circulation 2000, 102(3):357-363. juill 18.
60. Farivar A.S., Delgado M.F., McCourtie A.S., Barnes A.D., Verrier E.D., Mulligan M.S. Crosstalk between thrombosis and inflammation in lung reperfusion injury. Ann Thorac Surg 2006, 81(3):1061-1067. mars.
61. Favreau F., Thuillier R., Cau J., Milin S., Manguy E., Mauco G., et al. Anti-thrombin therapy during warm ischemia and cold preservation prevents chronic kidney graft fibrosis in a DCD model. Am J Transplant 2009, 10(1):30-39.
62. Giraud S., Thuillier R., Belliard A., Hebrard W., Nadeau C., Milin S., et al. Direct thrombin inhibitor prevents delayed graft function in a porcine model of renal transplantation. Transplantation 2009, 87(11):1636-1644.
63. Benigni A., Morigi M., Remuzzi G. Kidney regeneration. Lancet 2010, 375(9722):1310-1317. avr 10.
64. Duffield J.S., Humphreys B.D. Origin of new cells in the adult kidney: results from genetic labeling techniques. Kidney Int 2011, 79(5):494-501. mars.
65. Thadhani R., Pascual M., Bonventre J.V. Acute renal failure. N. Engl J Med 1996, 334(22):1448-1460. mai 30.
66. Jayle C., Faure J.P., Thuillier R., Goujon J.M., Richer J.P., Hauet T. Influence of nephron mass and a phosphorylated 38 mitogenactivated protein kinase inhibitor on the development of early and long-term injury after renal warm ischaemia. Br J Surg 2009, 96(7):799-808. juill.
67. Lan R., Geng H., Polichnowski A.J., Singha P.K., Saikumar P., McEwen D.G. PTEN loss defines a TGF-β-induced tubule phenotype of failed differentiation and JNK signaling during renal fibrosis. Am J Physiol Renal Physiol 2012, 302(9):F1210-F1223. mai.
68. Liu Y. Renal fibrosis: new insights into the pathogenesis and therapeutics. Kidney international 2006, 69(2):213-217.
69. Fine L.G., Norman J.T. Chronic hypoxia as a mechanism of progression of chronic kidney diseases: from hypothesis to novel therapeutics. Kidney Int 2008, 74(7):867-872. oct.
70. Ko G.J., Boo C.-S., Jo S.-K., Cho W.Y., Kim H.K. Macrophages contribute to the development of renal fibrosis following ischaemia/reperfusion-induced acute kidney injury. Nephrol Dial Transplant 2008, 23(3):842-852. mars.
71. Hertig A., Verine J., Mougenot B., Jouanneau C., Ouali N., Sebe P., et al. Risk factors for early epithelial to mesenchymal transition in renal grafts. Am J Transplant 2006, 6(12):2937-2946. déc.
72. Rifkin D.E., Coca S.G., Kalantar-Zadeh K. Does AKI truly lead to CKD?. J Am Soc Nephrol 2012, 23(6):979-984. juin.
73. Hsu C. Yes, AKI truly leads to CKD. J Am Soc Nephrol 2012, 23(6):967-969. juin.